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Background: Introduction of balloon dilatation has become the standard treatment
for recurrent aortic arch obstruction and has changed the therapeutic approach to
patients with this disorder.
Objectives: Whether all patients with recurrent aortic arch obstruction are candi-
dates for balloon dilatation remains unanswered. In addition, only few reports have
tried to compare the results between patients undergoing balloon dilatation or redo
operations.
Methods: Since 1983, 97 patients underwent reintervention for recurrent aortic arch
obstruction (42 dilations and 55 reoperations). Eight had immediate unsuccessful
dilatation and were shifted to the surgical group (n  63). The median age at
reintervention was 21.7 months (10 days-45 years), and the median delay was 13.6
months (7 days-17 years). Anatomy of the aortic arch oriented the surgical approach
to treat arch hypoplasia. It could be performed through a left thoracotomy in 52
patients, with extended end-to-end anastomosis in 34 patients, subclavian flap repair
in 9 patients, conduit insertion in 6 patients, and patch enlargement in 3 patients.
More recently, an anterior approach with cardiopulmonary bypass without circula-
tory arrest was applied to enlarge the patch in all the aortic arches.
Results: There was one early death in the surgical intervention group and 2 late
deaths in the dilation group. Major complications and recurrence were higher in the
dilated group (4 vs 0, P  .01, and 14 vs 5, P  .0004, respectively). At a mean
follow-up of 11.8 4.1 years in the surgical intervention group and 7.5 2.5 years
in the dilated group, systemic hypertension was normalized in all but 5 patients in
the surgical intervention group and 6 patients in the dilated group.
Conclusion: Reoperation for recurrent aortic arch obstruction can be performed
safely, with low rates of mortality and morbidity. This approach should be consid-
ered versus balloon angioplasty, especially in patients older than 4 years and in the
presence of aortic arch hypoplasia.
Aortic coarctation repair either associated or not with intracardiaclesions with or without aortic arch hypoplasia is now performed inthe vast majority of centers, with excellent early functional re-sults. The recurrence rate of aortic recoarctation remains a matterof concern and varies according to the series between 5% and50%,1-4 with age at repair being the most significant risk factor for
recoarctation1-3 in addition to the anatomy of the aortic arch.1,5 Strategies to deal
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with this lesion have evolved with time. In addition to
reoperation, balloon dilation has gained in popularity be-
cause of its efficiency and less invasive approach. Twenty
years after the first balloon dilation for recurrent aortic
coarctation described by Singer and colleagues,6 this pro-
cedure seems to provide satisfactory functional results, but
it is not without complications, such as surgical interven-
tion. It is our belief that the time has come to compare the
results of both procedures in terms of results and indica-
tions. Indeed, in several cases the aortic arch anatomy is not
favorable for balloon angioplasty, leaving an operation as
the single acceptable approach for repair. Furthermore, sev-
eral patients present with a rather abnormal aortic arch
anatomy, no gradient across the suture line, and systemic
hypertension at rest or during exercise long after coarctation
repair. Whether to propose life-long medical treatment to
control hypertension or to surgically restore an anatomic
aortic arch remains controversial, and the risks of each
approach should be well evaluated. We report our experi-
ence with the management of aortic recoarctation treated
either by means of balloon angioplasty or surgical interven-
tion and try to delineate the optimal approach for this lesion.
Patients and Methods
Between 1983 and 2001, 955 patients were operated on for aortic
coarctation or interrupted aortic arch (IAA) at the Surgical Center
Marie-Lannelongue. During this period, 97 (10.2%) patients had a
recoarctation severe enough to require reintervention.
Definitions and Indications for Reintervention
The aortic arch was defined as lying between the brachiocephalic
artery and the ductus arteriosus and as comprising 3 segments: the
proximal transverse arch between the brachiocephalic and left
carotid arteries, the distal transverse arch between the left carotid
and left subclavian arteries, and the isthmus between the left
subclavian artery and the ductus arteriosus.1
Aortic recoarctation is considered when, after initial discharge
of a patient who underwent aortic coarctation repair with a good
result, echocardiographic Doppler studies demonstrate systolic
gradient across the suture line with diastolic prolongation irrespec-
tive of the degree of systolic gradient. In the absence of diastolic
prolongation but with systolic gradient, exercise testing, when
feasible, can reveal a diastolic prolongation and therefore can be
used to confirm the diagnosis of recoarctation. The same definition
was accepted for residual coarctation but applied to patients pre-
senting these Doppler echocardiographic criteria immediately after
the initial aortic arch repair or before discharge. Reintervention is
considered in the presence of symptoms such as systemic hyper-
tension or when echocardiography demonstrates a hypertrophic or
dilated left ventricle.
The criterion for defining aortic arch hypoplasia was a diameter
of the proximal aortic arch and the distal transverse arch of less
than 60% and 50%, respectively, of that of the ascending aorta.1
Balloon dilation was introduced in our institution in 1987, and
therefore before this date, all patients with recoarctation underwent
reoperation (24 patients). Thereafter, indication for each technique
was generally left to the referring physician’s preference.
Initial Operation
Ninety-seven patients required reintervention to enlarge their aor-
tic arches. There were 59 male and 38 female patients. Median age
at first operation was 17.7 days, ranging from 2 days to 19 years
(68 [70%] patients were neonates and only 8 were older than 3
years), and median weight was 3.5 kg (range, 1.2-65 kg). In all
cases the initial procedure was performed at our institution. The
coarctation was isolated in 33 (34%) patients. Associated cardiac
lesions were present in the remainder and included ventricular
septal defect (VSD) in 42 patients, of whom 7 had an IAA;
transposition of the great arteries (TGA) with VSD in 9 patients;
TGA with intact septum and coarctation in 1 patient; multilevel
left ventricular obstruction in 9 patients; hypoplastic left heart
syndrome in 1 patient; and “other” in 2 patients. Aortic arch
hypoplasia, as defined above, was present in 58 patients (including
7 with an IAA)
The initial procedure was performed with the following tech-
niques: extended end-to-end anastomosis in 70 patients, subclavian
flap repair in 7 patients, implantation of the descending aorta in the
ascending aorta in 6 patients, anatomic conduit in 3 patients, and
patch enlargement either with homograft or synthetic material in
11 patients. This was done through a left thoracotomy in 75
patients and through a median sternotomy in 22 patients (cases
involving with intraventricular repair, including 6 with TGA; 7
with an IAA; 7 with VSD, with a left ventricular outflow tract in
2 patients; 1 with aortic valve stenosis; and 1 with hypoplastic left
heart syndrome).
The mean gradient after the initial operation was 18.8 mm Hg
(range, 0-45 mm Hg). Four patients had significant residual gra-
dient essentially caused by important residual hypoplasia of the
aortic arch.
Associated Procedures
The surgical approach has changed with time in complex cases,
evolving from palliative care to the single-stage approach. The
latter was performed in 22 patients and included concomitant
closure of the VSD in 14 patients (7 with coarctation syndrome
and 7 with an IAA), arterial switch operation with VSD closure in
6 patients, aortic commissurotomy in 1 patient, and the Norwood
stage I operation in 1 patient. Patients who underwent a palliative
approach had associated pulmonary artery banding in 20 cases.
Five patients had a VSD that was too small and did not require any
specific procedure in association with the coarctation repair. The
pulmonary artery banding was taken off at a mean of 2.1 years
after the initial repair, with closure of the VSD in 13 patients.
Reintervention
After the initial coarctation repair, the patients were followed by
the referring cardiologist for measurement of resting blood pres-
sure and echocardiography. Resting pressure gradients across the
coarctation were obtained by means of Doppler echocardiographic
studies, and if any significant abnormality was detected, the pa-
tients were re-explored at our institution by means of echocardi-
ography, catheterization, or both. Recoarctation was considered
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effective when a diastolic prolongation of the gradient on Doppler
evaluation was present. Before 1987, all the patients presenting
with recoarctation underwent a redo operation. More recently and
since balloon angioplasty was introduced, they are preferentially
managed by means of balloon angioplasty.
Forty-two patients were scheduled for balloon dilation, and 55
were scheduled for surgical intervention (Figure 1).
The median time between aortic arch repair and recoarctation
repair was 13.6 months (range, 7 days-17 years). The median age
at reintervention was 21.7 months (range, 10 days-45 years).
Indications for reintervention were systemic hypertension in 60
patients, left ventricular failure in 18 patients, and major gradient
with diastolic coarctation flow in 19 patients. Mean gradient across
the coarctation was 47.5  19.3 mm Hg.
A hypoplastic aortic arch was present in 24 (25%) patients (6 in
the dilation group and 18 in the surgical intervention group).
As seen above and before 1987, all recoarctations were treated
with a redo operation. Then after all patients had an angiography
and in the absence of evident arch hypoplasia, balloon dilation was
undertaken. Early results after angioplasty were considered suc-
cessful when the aortic systolic gradient dropped to less than 15
mm Hg without any residual diastolic gradient and with a site of
dilation presenting a normal or subnormal diameter and morphol-
ogy. The result was considered poor but acceptable when the
postangioplasty diastolic gradient disappeared but a systolic gra-
dient higher than 15 mm Hg persisted, and angioplasty was con-
sidered unsuccessful when the diastolic gradient remained present
after the dilation.
Surgical Procedures
In patients who underwent redo operations, the surgical approach
was dictated by the aortic arch anatomy (Figure 2).
Those having a normal arch or a moderate hypoplastic distal
arch (n 52) were operated on through a left thoracotomy, and the
intraoperative management was significantly the same as that for
primary coarctation repair. Resection of the restricted area with
extended end-to-end anastomosis was performed in 34 patients,
whereas 9 patients had subclavian flap angioplasty and 3 had
polytetrafluoroethylene (PTFE)* patch enlargement. The remain-
ing 6 had conduit interposition, 2 of whom had a replacement of a
first conduit inserted at the first procedure. In the other 4 patients,
conduit interposition was performed because after the resection of
the restricted aortic segment, the proximal and distal parts of the
aorta were too distant from each other to permit a safe direct
suture.
Circulatory support during reoperation was used only in the 2
patients who needed replacement of their conduits. In one patient
it was established between the femoral artery and the femoral vein,
and in the other patient it was established between the left atrium
and the femoral artery.
Patients with residual hypoplastic proximal or transverse aortic
arch (n  11), associated (9 patients) or not (2 patients; Figures 3
and 4, A) to an aortic coarctation were approached through a
median sternotomy during cardiopulmonary bypass (CPB) to en-
large the aortic arch. (Figure 4, B and C). In those patients, 2
techniques of CPB were performed to avoid deep hypothermic
circulatory arrest. In 10 patients deep hypothermic (20°C) CPB
was instituted between the ascending aorta and the right atrium, the
aortic cannula was then mobilized into the innominate artery to
perform a selective anterograde brain perfusion, and the other
supra-aortic vessels were crossclamped, as was the aorta. The
cerebral flow was decreased so as to obtain a mean 50 mm Hg
proximal pressure monitored in the right radial artery. Cardiople-
gia was injected in the aortic root, and the aortic clamp was
removed. The aortic arch was then incised in its concavity starting
below the innominate artery and progressing toward and then far
below the recoarctation area. The back flow from the descending
aorta is sucked with a sucking probe, and an open approach for
patch enlargement of the aortic concavity was performed with a
PTFE patch in 3 patients, a homograft patch in 5 patients, and a
double-reversed left carotid–left subclavian flap to enlarge a re-
sidual hypoplasia of the transverse arch without residual coarcta-
tion in 2 patients. Three of these 10 patients did not need any
mobilization of the aortic cannula because the aortic clamp could
*Gore-Tex patch, registered trademark of W. L. Gore & Associates, Inc,
Newark, Del.
Figure 1. Procedures in 97 patients with RAAO.
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be applied safely, allowing a complete repair, as described by
DeLeon and associates.7 One of these patients had associated
aortic valve commissurotomy.
The second CPB technique recently applied in 1 patient com-
bined double-femoral and innominate artery cannulations for ar-
terial injection and moderate hypothermia (30°C). When the supra-
aortic trunks were isolated, the descending aorta was crossclamped
beyond the recoarctation site, and cardioplegia was injected in the
aortic root. Patch enlargement of the aortic concavity was then
performed as previously described.
Follow-up and Statistical Analysis
All but 5 survivors were traced, and functional results were re-
corded. New York Heart Association class, systemic hypertension,
medication, and gradient across the aortic arch and isthmus were
noted. Comparisons between 2 groups were performed by using
the 2 test for noncontinuous variables and the Student t test for
continuous data. Survival and freedom from recoarctation rates
were constructed by using Kaplan-Meier curves.
Results
Dilation Group
Data on the dilation group are shown in Figure 5. There
were no early deaths among the 42 patients who had balloon
dilation. There were 2 (4.8%) late deaths 2 and 1.5 years
after aortic angioplasty, respectively. Both patients were
older than 5 years when they had their aortic recoarctation
dilated. In one patient death was not cardiac related, and the
last Doppler echocardiographic control has shown no resid-
Figure 2. Surgical procedures are dictated by the anatomy of the aortic arch. EEEA, Extended end-to-end
anastomosis.
Figure 3. Angiogram of a residual proximal heart hypoplasia after successful treatment of coarctation by means
of reversed subclavian flap.
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Figure 4. A, Computed tomographic scan showing residual proximal arch hypoplasia after successful treatment of
coarctation by means of end-to-end anastomosis. This patient had systemic hypertension. B, The same patient when
undergoing reoperation: preoperative view. C, Patch enlargement of all the aortic arches.
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ual gradient. In the other patient death occurred in the
context of heart failure, and the last control showed a
residual systolic gradient of 30 mm Hg.
Immediate results. Data on immediate results are shown
in Table 1. Results were considered good in 22 (52%)
patients, with a residual systolic gradient of less than 15 mm
Hg and an almost normal aortic arch anatomy recovery. The
mean age of this group was 7.1  55 months, and the
restricted area was localized to the isthmus without associ-
ated arch hypoplasia in all cases. Seven early failures were
observed in this cohort, with an unchanged gradient across
the recurrent aortic arch obstruction (RAAO). In 13 remain-
ing patients the early result was evaluated as poor but
acceptable, with a recurrent coarctation within the few days
after angioplasty in 7 patients, thus leading to a failure rate
of 33% (14/42). Eight of these 14 patients were reoperated
on, 6 of them within a mean time of 1.4 months after
angioplasty and the others after 6 months and 2 years,
respectively. The surgical procedures were achieved by
means of thoracotomy in 5 patients, including 1 extended
end-to-end anastomosis, 3 subclavian flaps, and 1 anatomic
prosthetic graft, and by means of sternotomy, as described
above, in the remaining 3 patients. The other 6 patients are
awaiting reintervention.
When analyzing this 14-patient subgroup in whom bal-
loon dilatation failed (Table 2), 8 were older than 4 years,
and 5 had a more or less severe aortic arch hypoplasia.
Thirteen of the 42 dilated patients were older than 4
years. In 3 patients the maneuver was unsuccessful, and the
results were poor in 6 patients, with rapid recoarctation in 3.
Four patients had good early results, but one died 2 years
later from cardiac failure (transposition of the great arteries
who had a Senning procedure in infancy).
Immediate complications. Data on immediate compli-
cations are shown in Table 1. Complications occurred in 7
(16.6%) patients, with 3 minor complications (absence of
femoral pulse successfully treated with platelet antiag-
gregant) and 4 (9.5%) major complications, including 1
acute ischemia of the inferior limb that recovered with
anticoagulant treatment, 1 ischemic cerebral stroke that
partially recovered, 1 right coronary dissection with myo-
TABLE 1. Early results, dilation versus surgical interven-
tion
Dilation
Surgical
intervention P value
Death 0 1 (1.6%) .4
Minor
complications
3 (7.6%) 5 (8%) .8
Major
complications
4 (9.5%) 0 .01
Poor result 7 (16.5%) 5 (8%) .17
Failure 7 (16.5%) 0 .0007
TABLE 2. Risk factors for failure of reintervention
Dilation
Surgical
intervention P value
Age
4 y 8/12 0/12 .0001
4 y 5/30 5/51 .37
Arch
Hypoplasia 5/6 0/18 .0001
Normal 9/36 5/45 .1
Figure 5. Dilatations: early and late results.
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cardial infarction requiring a stent implantation into the
right coronary artery of a 1.3-month-old patient, and a
severe systemic valve regurgitation associated with a failed
dilatation leading to an emergency redo operation in a
patient who underwent a first-stage Norwood procedure 1
month before.
Late results. Data on late results are shown in Table 3.
At a mean follow-up of 7.5  2.5 years, no late complica-
tions were observed. The 22 patients with a good immediate
result remained stable, leading a normal life without treat-
ment. They have a 10 mm Hg mean gradient (range, 0-20
mm Hg). Seven of the 13 patients with poor initial results
worsened toward recoarctation, and 1 underwent reopera-
tion, whereas the 6 other patients are being treated for
systemic hypertension and awaiting surgical intervention.
The remaining 6 patients have a stable residual systolic
gradient and remain asymptomatic. Finally, none of the
patients in the dilated group had any aortic aneurysms.
Surgery Group
There was 1 (1.6%) perioperative death among all the
patients undergoing reoperation (n  63). This patient had
a multilevel left-sided obstruction with a small left ventri-
cle. He had his initial coarctation repair at 2 weeks of life
(extended end-to-end anastomosis by means of thoracot-
omy). One month later, he underwent reoperation for reco-
arctation and aortic valve commissurotomy by means of
sternotomy. He died 3 days later in the intensive care unit
because of pulmonary artery hypertension. At a mean fol-
low-up of 11.8  4.1 years, no late deaths occurred.
Data on early and late morbidity are shown in Tables 1
and 3. The postoperative course was uneventful in the vast
majority of patients, and only 5 had minor pulmonary com-
plications, such as pneumothorax or pleural effusions. In
particular, none of the patients had any neurologic discom-
fort, such as spinal cord ischemia, phrenic nerve injuries, or
recurrent nerve paralysis. One patient underwent revision
for bleeding.
Five (8%) patients undergoing reoperation still had
RAAO with persistent systemic hypertension. Two (3.2%)
of them needed a second reoperation. Both of them had their
first reoperation through a left thoracotomy that obviously
left some degree of aortic arch hypoplasia untreated. They
underwent reoperation through a sternotomy with CPB
without circulatory arrest. The first patient underwent reop-
eration in 1985, and because of severe scarring, he had a
PTFE tube graft between the ascending and descending
aortas associated with subaortic stenosis relief. The second
patient more recently underwent enlargement of all the
aortic arches, as described above, in association with a
subaortic resection.
Follow-up was available for 88 (90%) patients and
ranged from 11 months to 17 years. At a mean follow-up of
11.8  4.1 years, 89% (79 patients) of the patients were
normotensive and asymptomatic, 5 of them needing medical
control of their hypertension; 3 of these 5 patients have
residual gradients of approximately 20 mm Hg, and 2 have
residual gradients of 30 mm Hg.
None of the 11 patients who had patches at the first
reoperation had any aneurysms.
During the follow-up period, 3 patients underwent reop-
eration for subaortic stenosis and underwent membranec-
tomy and myectomy. One patient had a Ross-Konno oper-
ation for aortic and subaortic stenosis.
Statistical Analysis
Analysis of Kaplan-Meier curves comparing results after
reintervention on the aortic arch (Figure 6) shows that
recurrence after dilatation occurs immediately after angio-
plasty in the majority of patients (85%), whereas after
surgical intervention, recurrence might occur many years
later. In addition, comparison between the 2 therapeutic
approaches shows that the benefice of balloon dilatation is
significantly reduced in patients older than 4 years and in
those with persistent hypoplastic transverse arches.
Discussion
During the past 18 years, 97 patients presented with recur-
rent aortic coarctation after a primary repair of aortic arch
TABLE 3. Late results, dilation versus surgical intervention
Dilation
Surgical
intervention P value
Follow-up 7.5 y  2.5 11.8 y  4.1
Death 2 0 .08
Recurrence 14 5 .0004
Gradient 26.2  14 14.2  8.3 .001
Symptoms 6 5 .3
Figure 6. Kaplan-Meier curve for freedom from recurrence after
reintervention for RAAO.
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obstruction. As in other centers,8 the recurrence rate repre-
sents 10% of the patients operated on. It is admitted that risk
factors for this complication are initial repair at less than 2
weeks of age and the size of the transverse arch.1-5 Dodge-
Khatami and colleagues,5 in a 40-year review, showed that
simple end-to-end anastomosis and subclavian flap repair
had the highest incidence of recoarctation, especially when
associated with aortic arch hypoplasia.
Aortic recoarctation is considered in our study when,
after initial discharge of a patient who underwent aortic
coarctation repair with a good result, Doppler echocardio-
graphic studies demonstrate systolic gradient across the
suture line, with diastolic prolongation irrespective of the
degree of systolic gradient. Reintervention was decided
when symptoms such as systemic hypertension were present
or when echocardiography demonstrated a hypertrophic or
dilated left ventricle. The primary objective of this study
was to demonstrate that surgical intervention in recoarcta-
tion remains a safe option, with excellent early and late
results. Indeed, since aortic dilation was introduced, the
choice between the 2 methods is open to clinicians with on
the one hand a less aggressive and attractive procedure that
should treat the lesion at a lower cost and shorter hospital
stay and on the other hand an aggressive approach at higher
cost and longer hospital stay. As with other institutions, the
first option, namely balloon angioplasty, was adopted in our
institution as the procedure of choice, and after its introduc-
tion, a large number of patients underwent this procedure.
When retrospectively analyzing the results of each ap-
proach, the data require some comments. It seems that some
patients with RAAO are better managed by one or the other
method. Patients who have recurrent coarctation without
associated aortic arch hypoplasia and are younger than 4
years are better cured by means of balloon dilatation,
whereas the others seem to be better candidates for redo
surgical intervention. The main goal of the latter is to restore
an anatomic aortic arch, and therefore analysis of the anat-
omy of the aortic arch is one of the most relevant points
because it will dictate the surgical strategy.
Preoperative investigations, including angiography,
magnetic resonance image scanning, echocardiography, and
Doppler scanning are necessary to allow the choice of
appropriate therapeutic method (operation/dilation) or sur-
gical strategy (sternotomy/thoracotomy) at reintervention. If
the site of RAAO is proximal or if the aortic arch remains
hypoplastic, the lesion is preferentially approached through
a median sternotomy with CPB and no circulatory arrest. In
the other instances, a left thoracotomy approach is recom-
mended.
When comparing surgical intervention and dilation, re-
sults do not show any statistical difference in early and late
mortality between the 2 methods. On the other hand, anal-
ysis of early and late morbidity seems to demonstrate that
surgical repair is safer, effective, and has a low incidence of
persistent RAAO and complication, as demonstrated by
others.8,9 In particular,10 no neurologic discomfort, such as
spinal cord ischemia, phrenic nerve injuries, or recurrent
nerve paralysis, was encountered, but this risk remains
difficult to discern from the literature and is constantly
addressed either by descending aorta perfusion or hypother-
mia. Morbidity after balloon angioplasty is not infrequent,
with mainly cerebrovascular accidents and femoral artery
injuries.
Also in terms of functional results, a redo operation
favorably compares with balloon angioplasty, but the sta-
tistical difference becomes nonsignificant if one analyses
the optimal technique for good indication. Namely, if bal-
loon angioplasty is applied to younger patients without or
with minor hypoplasia of the aortic arch, the functional
result should be as excellent as after surgical intervention.
Although the present data seem to favor redo operations
in older patients with RAAO, some authors have implanted
intravascular stents for this indication with good short-term
results,11,12 but long-term outcome remains to be evaluated.
Aortic aneurysms develop in up to 14% of patients after
dilation and are also frequent after surgical intervention,
especially when a Dacron patch is used. This kind of com-
plication was not observed in the 3 subgroups, particularly
after surgical special care was applied not to use these
patches through a left thoracotomy because we believe that
aortic aneurysms might develop when inserted in the free
space of the pleural cavity, which is not the case when the
patch is inserted in the concavity of the aorta through a
median sternotomy.
Long-term results show that 89% of the patients are
normotensive and asymptomatic. Five (11%) of them need
medical control of their hypertension.
In conclusion, therapeutic strategy in the presence of
RAAO is oriented toward dilatation when occurring in
infants less than 4 years of age and when no aortic arch
hypoplasia is present. In the presence of any arch hypopla-
sia, patients are better managed by redo surgical interven-
tion, which can be done by means of thoracotomy with
extended end-to-end anastomosis when only the distal aortic
arch is hypoplastic and by means of sternotomy with bypass
and without circulatory arrest by using patch enlargement of
all the aortic arches when the proximal arch is also hypo-
plastic. Awaiting more experience with the stents, if a child
or an adult needs a reintervention, the therapeutic preference
is surgical intervention.
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Discussion
Dr Carl L. Backer (Chicago, Ill). It is a great privilege for me
to discuss this outstanding review of recoarctation management.
The outcome reported here with reoperation for recoarctation is
truly superb, with only 1 death (in a complex neonate) in 63
patients. There were no episodes of postoperative paraplegia, and
only 2 patients required a second reoperation.
In contrast, of the 42 patients having transcatheter balloon
dilatation, 14 have undergone or are awaiting a reoperation, and 4
had major complications. In light of these excellent results, the
question I believe the authors should have asked in the title is this:
“Is balloon dilatation still indicated in recurrent aortic arch ob-
struction?”
Our results at Children’s Memorial Hospital are quite similar to
yours. We reported a 40-year experience with more than 30 pa-
tients having recoarctation surgery with no mortality and no para-
plegia. In our series 30% of the patients who had a balloon
dilatation required an eventual operative intervention. However,
we had no major complications from balloon dilatation at our
institution. I believe that the learning curve for balloon dilatation
has occurred in recoarctation and that the results of balloon dila-
tation are improving.
Recent use of stents and covered stents will continue to show
improvement with recoarctation balloon dilatation. What I believe
is important is a continued collaboration between the surgeon and
the pediatric interventional cardiologist to define the optimal man-
agement strategy for these patients at the individual institutions.
I have several questions.
We used a recoarctation analysis to identify what we believed
was the best primary operation for coarctation. Can you make a
comment about your current primary procedure of choice for
coarctation?
My next question relates to the prevention of paraplegia. What
intraoperative techniques did you use to attain the excellent result
of no postoperative paraplegia in this large series? Also, as a
corollary to this question, when did you use CPB support, aside
from those patients operated on through a median sternotomy?
My final question relates to a question of definitions. It was
interesting to me that you defined recoarctation in your article as
systolic echocardiographic gradient plus diastolic flow prolonga-
tion. You never mentioned arm-leg blood pressure gradients or
cardiac catheterization gradients. Do you still consider a 20-mm
arm-leg gradient to be the gold standard for defining recoarctation,
or do you believe the echocardiographic criteria have supplanted
this?
I very much enjoyed reviewing this manuscript and believe that
this is an important contribution to our knowledge of the results of
recoarctation surgery.
Dr Zoghbi. Thank you, Dr Backer, for your comments.
I am going to start with the third question, which is about the
definition of recoarctation or coarctation. It is true that this defi-
nition remains under debate. In our experience and on the basis of
the literature, we have chosen to define the coarctation when
diastolic prolongation of the flow is present at any site of the aortic
arch. When reviewing the patients, indeed, some of them had
normal dimension of their aortic segments at the site of primary
repair with only diastolic gradient. These patients presented with
systemic hypertension, and at reoperation, we found a restricted
aortic diameter at the site of primary repair. We have never seen
false-positive cases with this definition.
Regarding the prevention of cardioplegia, when recoarctation
repair is done by means of sternotomy, patients undergo CPB with
deep hypothermia. But for patients having a thoracotomy, systemic
pressure is monitored at the radial and femoral sites, and if femoral
pressure decreases to less than 50 mm Hg at crossclamp time, CPB
is done between the femoral artery and the femoral vein or the
pulmonary artery of the left atrium. In addition, when we consider
that the reoperation is going to be long, with a long clamping time,
cardiopulmonary circulatory support is also provided.
Actually, in our institution all the patients who present with
recoarctation undergo balloon dilation, which is probably the same
as in other centers. In this study we present our results, and we find
that in patients older than 4 years, the recurrence rate is very high.
We still do not have experience with stenting, but perhaps this is
going to improve the results. In the presence of aortic hypoplasia,
surgical intervention is the only indication, and dilation has no
place.
Dr Backer. And what is your primary procedure of choice for
coarctation?
Dr Zoghbi. The primary procedure is still extended end-to-end
anastomosis, which has been done in our institution for more than
10 years and provides satisfactory results, especially when there is
no proximal hypoplasia of the aortic arch.
Dr Zahid Amin (Omaha, Neb). Clearly the balloon dilation
for recurrent coarctation is the procedure of choice in the
United States. The data you presented have combined arch
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